Tower Research Capital LLC TRC lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 259.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,553 shares of the biopharmaceutical company’s stock after acquiring an additional 13,392 shares during the period. Tower Research Capital LLC TRC’s holdings in Regeneron Pharmaceuticals […]
Rhenman & Partners Asset Management AB reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,000 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the […]
Rhenman & Partners Asset Management AB reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,000 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the […]
Taurus Asset Management LLC lowered its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 16,054 shares of the biopharmaceutical company’s stock after selling 73 shares during the quarter. Regeneron Pharmaceuticals accounts […]
US Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,941 shares of the biopharmaceutical company’s stock after acquiring an additional 310 shares during […]
ProVise Management Group LLC increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,486 shares of the biopharmaceutical company’s stock after purchasing an additional 47 shares during the quarter. […]
Intech Investment Management LLC increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 119.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 18,593 shares of the biopharmaceutical company’s stock after purchasing an additional 10,104 shares during the quarter. Intech Investment Management […]
Johnson Financial Group Inc. cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 867 shares of the biopharmaceutical company’s stock after selling 256 shares during the period. Johnson Financial Group Inc.’s […]
Apexium Financial LP Purchases New Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals (NASDAQ:REGN) Receives New Coverage from Analysts at Evercore ISI tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.